Font Size: a A A
Keyword [Contrast Induced Nephropathy]
Result: 181 - 200 | Page: 10 of 10
181. Experimental Study On The Protective Effect Of ATP-Sensitive Potassium Channel Opener In Contrast Nephropathy
182. Efficacy Of Intensive-dose Atorvastatin In Preventing Contrast Induced Nephropathy In Elderly Patients With CHD Undergoing Percutaneous Coronary Intervention
183. The Prevention Of Intravenous Infusion Of Nicorandil On Contrast-induced Nephropathy In Patients With Mild And Moderate Renal Insufficient
184. Meta-analysis Of Reduced Glutathione For Prevention Of Contrast-induced Nephropathy
185. A Clinical Study Of The N-Acetylcysteine In Prevention Of Contrast-Induced Nephropathy After Percutaneous Coronary Intervention
186. The Association Of The Expression Of Plasma Endothelial Microparticle With Contrast-Induced Nephropathy In Patients With Coronary Angiography
187. Dynamic Change Of Renal Function In Patients With Cerebrovascular Disease After Digital Subtraction Cerebral Angiography
188. The Predictive Value Of Preoperative Urinary Microalbumin To Creatinine Ratio Level In Early Diagnosis Of Contrast-induced Nephropathy
189. Effects Of Hyperglycaemia And Elevated Glycosylated Haemoglobin On Contrast-induced Nephropathy After Coronary Angiography
190. Preventive Effects Of Remote Ischemic Preconditioning On Contrast Induced Nephropathy
191. The Effects Of Nicorandil Combine With Trimetazidine On Contrast-induced Nephrophathy Undergoing Elective Percutaneous Coronary Intervention
192. The Clinical Evaluation Of Contrast Media Affect On The Renal Function In Patients With Heart Failure
193. The Clinical Study Of Jiahua Tablet In The Prevention And Treatment Of Patients With Contrast Induced Nephropathy After Aoronary Angiography Or Interventional Therapy
194. Meta-analysis Of Vitamin E In The Prevention Of Contrast-induced Nephropathy
195. Prevalence And Predictors Of Contrast-induced Nephropathy(CIN)in Patients With ST-segment Elevation Myocardial Infarction(STEMI)undergoing Percutaneous Coronary Intervention(PCI): A Meta-analysis
196. The Safety Evaluation Of Iodine Contrast Agent In Patients Undergoing Coronary Intervention
197. Clinical Study Of Hypotonic Non-ionic Contrast Agent On Renal Function In Patients With Coronary Interventions
198. Risk Factors And Prediction Models For Contrast-induced Nephropathy Following Coronary Angiography
199. Effects Of Low Dose Furosemide On Preventing Contrast Induced Nephropathy At The Basic Of Adequate Hydration In Patients With Percutaneous Coronary Intervention According To Left Ventricular End-diastolic Pressure And Brain Natriuretic Peptideat Levels
200. The Preventive Effect Of Coenzyme Q10 Combined With Atorvastatin On Contrast-induced Nephropathy After Percutaneous Coronary Intervention In Patients With Chronic Renal Insufficiency
  <<First  <Prev  Next>  Last>>  Jump to